Cardiovascular disease in primary Sjögren's Syndrome: Raising clinicians' awareness

M Casian, C Jurcut, A Dima, A Mihai, S Stanciu… - Frontiers in …, 2022 - frontiersin.org
In the ever evolving landscape of systemic immune mediated diseases, an increased
awareness regarding the associated cardiovascular system impairment has been noted in …

Evaluation and management of dry mouth and its complications in rheumatology practice

Z Khavandgar, BM Warner, AN Baer - Expert review of clinical …, 2024 - Taylor & Francis
Introduction The symptom of dry mouth has multiple potential etiologies and can be a
diagnostic clue to the presence of common systemic diseases encountered in rheumatology …

Regulation of MMP9 transcription by ETS1 in immortalized salivary gland epithelial cells of patients with salivary hypofunction and primary Sjögren's syndrome

B Noll, FB Mougeot, MT Brennan, JLC Mougeot - Scientific Reports, 2022 - nature.com
Primary Sjögren's syndrome (pSS) patients exhibit enhanced degradation of the salivary
epithelium initially through MMP9 overexpression. We assessed the expression of MMP9 …

Effect of adipose tissue-derived stem cells therapy on clinical response in patients with primary Sjogren's syndrome

F Li, J Lu, X Shi, D Li, T Zhou, T Jiang, S Wang - Scientific Reports, 2023 - nature.com
The purpose of this trial was to clinically assess the effect and safety of Adipose Tissue-
derived Stem Cells (ADSCs) treatment on primary Sjogren's Syndrome (pSS). In this 6 …

[HTML][HTML] Engineering cell therapies for autoimmune diseases: from preclinical to clinical proof of concept

S Oh, AS Payne - Immune Network, 2022 - ncbi.nlm.nih.gov
Autoimmune diseases are caused by a dysfunction of the acquired immune system. In a
subset of autoimmune diseases, B cells escaping immune tolerance present autoantigen …

B-cell receptor signaling is thought to be a bridge between primary Sjogren syndrome and diffuse large B-cell lymphoma

L Mohammadnezhad, M Shekarkar Azgomi… - International Journal of …, 2023 - mdpi.com
Primary Sjogren syndrome (pSS) is the second most common autoimmune disorder
worldwide, which, in the worst scenario, progresses to Non-Hodgkin Lymphoma (NHL) …

Abnormal changes of monocyte subsets in patients with sjögren's syndrome

Y He, R Chen, M Zhang, B Wang, Z Liao… - Frontiers in …, 2022 - frontiersin.org
Background Recent studies have proven the existence of distinct monocyte subsets, which
play a significant role in the development of some rheumatic diseases such as systemic …

The plasma exosomes from patients with primary Sjögren's syndrome contain epithelial cell–derived proteins involved in ferroptosis

X Peng, L Hou, X Wu, Z Liu, Y Wang, P Zeng… - Journal of Molecular …, 2023 - Springer
Primary Sjögren's syndrome (pSS) is an autoimmune disease represented by exocrine
gland epithelial cell lesions. However, the mechanism underlying these lesions remains …

Therapeutic effect of modified zengye decoction on primary Sjogren's syndrome and its effect on plasma exosomal proteins

Y Zeng, X Peng, Y Wang, L Hou, W Ma… - Frontiers in …, 2022 - frontiersin.org
Background: Modified Zengye Decoction (MZD), a traditional Chinese medicine, is an
effective treatment for patients with primary Sjögren's syndrome (pSS). Purpose: To evaluate …

Autoantigen TRIM21 (Ro52) assembles pro-inflammatory immune complexes following lytic cell death

EL Jones, B Demarco, MML de Jong, H Cai, S Hill… - bioRxiv, 2024 - biorxiv.org
Sjögren's disease (SjD) causes localised and systemic inflammation due to autoantibody
production against intracellular proteins, such as TRIM21/Ro52. TRIM21 is an E3 ubiquitin …